158 related articles for article (PubMed ID: 9840940)
1. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
[TBL] [Abstract][Full Text] [Related]
2. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
3. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
4. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
5. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
[TBL] [Abstract][Full Text] [Related]
6. Absence of TSG101 transcript abnormalities in human cancers.
Trink B; Pai SI; Spunt SL; Raman V; Cairns P; Jen J; Gabrielson E; Sukumar S; Sidransky D
Oncogene; 1998 May; 16(21):2815-8. PubMed ID: 9652749
[TBL] [Abstract][Full Text] [Related]
7. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
8. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
[TBL] [Abstract][Full Text] [Related]
9. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.
Jacob AN; Kandpal G; Kandpal RP
Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550
[TBL] [Abstract][Full Text] [Related]
10. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
11. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
[TBL] [Abstract][Full Text] [Related]
12. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
Hosokawa Y; Nagai E; Seto M
J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1.
Pettigrew CA; French JD; Saunus JM; Edwards SL; Sauer AV; Smart CE; Lundström T; Wiesner C; Spurdle AB; Rothnagel JA; Brown MA
Breast Cancer Res Treat; 2010 Jan; 119(1):239-47. PubMed ID: 19067158
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
[TBL] [Abstract][Full Text] [Related]
15. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.
Chang JG; Su TH; Wei HJ; Wang JC; Chen YJ; Chang CP; Jeng CJ
Br J Cancer; 1999 Feb; 79(3-4):445-50. PubMed ID: 10027311
[TBL] [Abstract][Full Text] [Related]
16. Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA.
Contos JJ; Chun J
Genomics; 2000 Mar; 64(2):155-69. PubMed ID: 10729222
[TBL] [Abstract][Full Text] [Related]
17. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
18. Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites.
Zhang L; Ge L; Parimoo S; Stenn K; Prouty SM
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):255-64. PubMed ID: 10229681
[TBL] [Abstract][Full Text] [Related]
19. Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues.
Xiao GH; Jin F; Yeung RS
Cell Growth Differ; 1995 Sep; 6(9):1185-91. PubMed ID: 8519695
[TBL] [Abstract][Full Text] [Related]
20. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.
Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB
Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]